Lipocine (LPCN) vs Neuphoria Therapeutics (NEUP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Lipocine (LPCN) has outperformed Neuphoria Therapeutics (NEUP) over the past year, losing 31.7% versus a loss of 81.8%. Neuphoria Therapeutics is the larger company by market cap ($18.1 million vs $15.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LPCN | NEUP |
|---|---|---|
| Share price | $1.93 | $3.35 |
| Market cap | $15.91M | $18.13M |
| 1-day change | -12.27% | -2.05% |
| YTD return | -72.60% | -11.86% |
| 1-year return | -31.68% | -81.78% |
| 5-year return | -88.55% | — |
| EPS (TTM) | $-1.85 | $-3.06 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $12.37 | $19.21 |
| 52-week low | $1.81 | $3.19 |
| Distance from 52-week high | -84.40% | -82.56% |
| Average volume | 1.68M | 162.11K |
| Shares outstanding | 8.24M | 5.41M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- LPCN has outperformed NEUP by 50.1 percentage points over the past year.
LPCN vs NEUP FAQ
Which is bigger, Lipocine or Neuphoria Therapeutics?
Neuphoria Therapeutics (NEUP) is larger, with a market capitalization of $18.13M compared with $15.91M for Lipocine (LPCN).
Which stock has performed better over the past year, LPCN or NEUP?
LPCN returned -31.68% over the past 12 months, compared with -81.78% for NEUP (price return, excluding dividends). Past performance does not predict future results.
Are Lipocine and Neuphoria Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.